Health
Azithromycin use for treating COVID-19 may increase risk of cardiac events – News-Medical.net
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization for the drug in treating COVID-19.
Another drug, azithromycin — a commonly-prescribed antibiotic — also is being inves…
-
Noosa News22 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation